Laserfiche WebLink
• <br /> breath test or other mechanism determined by management to be reliable will be subject <br /> to dismissal. <br /> VIII. Testing Procedure <br /> A. Tested Substances <br /> The City may test for any or all of the following drugs: <br /> • Alcohol <br /> • Amphetamines (Binhetamine, Desoxyn, Dexedrine) <br /> • Cannabinoids (i.e., marijuana, hashish) <br /> • Cocaine <br /> • Phencyclidine (PCP) <br /> • Methaqualone (Quaalude, Parest, Sopor) <br /> • Opiates <br /> • Opioids (Hydrocodone, Oxycodone, Hydromorphone, Oxymorphone) <br /> • Barbiturates(Phenobarbital, Tuinal, Amytal) <br /> • <br /> • Benzodiazophines (Ativan, Azene, Clonopin, Dalmane, Diazapam, Halcion, Librium, <br /> Poxipam, Restoril, Serax, Tranxene, Valium, Vertron, Xanax) <br /> • Methadone (Dolophine, Methadose) <br /> • Propoxyphene (Darvocet, Darvon N. Dolene) <br /> B. Consent Required <br /> Job applicants and employees will be asked to sign Consent to Testing Form. Refusal to <br /> execute the consent form constitutes a refusal to be tested, and will subject the <br /> employee/applicant to dismissal/failure to hire. <br /> C. Designated Laboratory <br /> Because of the potential adverse consequences of positive test results on employees, the <br /> City will employ a very accurate testing program. Specimen samples will be analyzed by a <br /> highly qualified, independent laboratory which has been selected by the City and certified by <br /> the appropriate regulatory agency. The name and address of the certified laboratory <br /> currently used by the City is on file with the Human Resources Department. <br /> D. Notification of Prescription Drug Use <br /> Applicants and employees will be given an opportunity prior to and after testing to, on a <br /> confidential basis, provide any information they consider relevant to the test including listing <br /> all drugs they have taken within the immediately preceding 30 day period, including <br /> prescribed drugs and to explain the circumstances of the use of those drugs in writing or <br /> other relevant medical information on a Drug Use Information Form, which information will <br /> be furnished to the Medical Review Officer (MRO) in the event of a positive confirmed result. <br /> Applicants and employees will also be provided with a notice of the most common <br /> medication by brand name or common name, as well as the chemical name which may alter <br /> or affect a drug test. <br /> E. Testing of Injured Employees <br /> (Reso)Sib Drug-Free Workplace Program-Rev 01182018 Page 12 of 41 1/18/2018 <br />